Register now

9 December 2020 13:00-16:00

A thousand paths to success - which one is yours?

Finding your fit among the variety of business models of the life science industry

Life science-companies have one thing in common: the need for money. When looking closer into the sources whereby money is attained, a variety of financing strategies unfolds. Which is the successful choice? They can be all, as long as you are able to roll with their respective business models. In this year’s SwedenBIO Summit, we follow the money of successful life science companies to explore the strategies behind their choice of funding, be it  VC, stock market, crowdfunding, or investment banking. Furthermore, what are the perks and pitfalls of the various types of funding? Find out in our first session, where we challenge high-profile financial actors to answer our member community's toughest questions. 

It can be difficult to source expertise or executive competence at the moment you need it, despite the fact that the Swedish life science community, as a whole, holds a tremendous pool of proficiency and experience. And when looking at the various strategies for sourcing talent, yet another colorful array of business models emerges. There are a variety of ways of sharing experiences across the community, by engagement in each other’s companies and the use of CRO´s, consultants, and interim executives. This session explores new and clever uses of human resources, with a focus on how to level-up your business by daring to exchange the know-how.  

Last but not least, we look into what´s lying ahead of us in 2021 with trendspotters deeply engaged in various parts of the life science ecosystem, to be crowned by the announcement of SwedenBIO Award winner of 2020! 

Covid information

Due to covid-19, this event will be broadcasted from Grand Hôtel but completely digital for all participants. We will use the Remo conference plattform which enables you to network with serendipity and great pleasure.

Program

13:00

WELCOME!

Introductory Note by Helena Strigård - Director General, SwedenBIO

Read more
13:10

SESSION 1: FOLLOW THE MONEY 🇸🇪

Finding Your Fit

Eric Kinnman - CEO, Abliva (former NeuroVive)

Read more

Money Talks

Stock Market: Peter Gönczi - CEO, Spotlight Group meets Adam Kostyal - SVP, Nasdaq
How to go public: Christina Östberg Lloyd - CEO, Pharmiva comments
Bank meets VC: Benedicte Kilander Bakke - Portfolio Manager, DNB Health Care Fund meets Maria Tell - Investment Manager, Almi Invest


Moderated by: Helena Strigård - Director General, SwedenBIO


🎤 Pop-up questions from members 

    Read more
    14:00

    Digital mingle

    👩🏽‍💻 Mingle with members and speakers through the Remo platform

        Read more
        14:30

        SESSION 2: DARE TO SHARE 🇸🇪

        A “Skavlan-talk” moderated by Frida Lawenius, Deputy Director General, SwedenBIO

        Appearances: 

        Björn Henriksson, CEO, Nordic Interim
        Maarten de Chateau, CEO Sixera Pharma and Buzzard Pharmaceuticals, etc.
        Martin Olovsson, CEO OnDosis
        Annika Muskantor, Interim CFO, Frideborg Consulting AB



        🎥 Talent talks

        Read more
        15:15

        Digital mingle

        🧑🏼‍💻 Meet SwedenBIO members and speakers - mingle at different virtual tables

        Read more
        15:45

        ⭐️SWEDENBIO AWARD⭐️ Presented in collaboration with HealthCap

        Green room interviews with nominated companies 

        The winner of the 14th SwedenBIO award will be announced 
        Lars Adlersson - Chair, SwedenBIO's board
        Johan Christenson - Partner, HealthCap


        Read more
        16:00

        Digital mingle





        Producent: Hanna Brodda, Mediefy

        Read more

        Speakers

        Helena Strigård
        Director General, SwedenBIO

        Read more

        Erik Kinnman
        CEO, Abliva

        Read more

        Peter Gönczi
        CEO, Spotlight Group

        Read more

        Adam Kostyál
        Senior Vice President, Nasdaq

        Read more

        Christina Östberg Lloyd
        CEO, Pharmiva

        Read more

        Benedicte Kilander Bakke
        Portfolio Manager, DNB

        Read more

        Maria Tell
        Investment Manager, Almi Invest

        Read more

        Frida Lawenius
        Deputy Director General, SwedenBIO

        Read more

        Björn Henriksson
        CEO, Nordic Interim

        Read more

        Maarten de Chateau
        CEO Sixera Pharma, CEO Buzzard Pharmaceuticals

        Read more

        Martin Olovsson
        CEO, OnDosis

        Read more

        Annika Muskantor
        Interim CFO, Frideborg Consulting

        Read more

        Lars Adlersson
        Chairman of the Board, SwedenBIO

        Read more

        Johan Christenson
        Partner, HealthCap

        Read more

        Organized by